4 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Astrocytoma of Brain: new trials by email Literature Review of Astrocytoma of Brain trials Research Report on Astrocytoma of Brain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) Re-resection, Temozolomide, Lomustine - Glioblastoma, Glioblastoma Multiforme | Recruiting | Jasper Gerritsen | 464 | 2023-01-01 | 2024-02-28 | |
| Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma Tislelizumab plus Bevacizumab - Astrocytoma of Brain | Phase 2 | Not yet recruiting | Henan Provincial People's Hospital | 70 | 2022-12-01 | 2022-09-27 |
| Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma Intranasal Modified Temozolomide - Glioma, Malignant, Gliosarcoma | Phase 1 | Completed | Center Trials & Treatment Europe | 30 | 2019-12-20 | 2023-04-25 |
| Impact of IDH Mutation and Adjuvant Chemo(radio)therapy on Survival Outcome in Grade II/III Astrocytoma IDH mutant-type, IDH wild-type - Astrocytoma, Astrocytic Tumors | Completed | asmaa salama ibrahim | 811 | 2018-01-01 | 2024-10-29 | |
| GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3) GliomaAI-Astro23 - Glioma, Glioma (Diagnosis) | Completed | Deep Learning Institute of Radiological Sciences | 1372 | 2017-03-14 | 2026-06-29 | |
| BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab Laboratory Biomarker Analysis, Pharmacological Study, Ubidecarenone Injectable Nanosuspension - Gliosarcoma, Recurrent Glioblastoma | Phase 1 | Completed | Seema Nagpal | 12 | 2017-01-04 | 2021-08-10 |
Astrocytoma (3) · Glioblastoma (2) · Glioma (2) · Gliosarcoma (2) · Brain Neoplasms (1) · Disease (1) · Lymphoma, Follicular (1)
Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Germ Cell and Embryonal (5) · Neoplasms, Glandular and Epithelial (5) · Neoplasms, Nerve Tissue (5) · Neoplasms, Neuroepithelial (5) · Neuroectodermal Tumors (5) · Glioma (3) · Astrocytoma (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1)
Temozolomide (2) · Bevacizumab (1) · Immunotherapy (1) · Lomustine (1) · Oncolytic Virotherapy (1) · Re-Irradiation (1) · Therapies, Investigational (1) · tislelizumab (1)
Center Trials & Treatment Europe (1) · Deep Learning Institute of Radiological Sciences (1) · Henan Provincial People's Hospital (1) · Jasper Gerritsen (1) · Seema Nagpal (1) · asmaa salama ibrahim (1)
United States (2) · Belgium (1) · Bosnia and Herzegovina (1) · Bulgaria (1) · China (1) · Egypt (1) · Georgia (1) · Germany (1) · India (1) · Netherlands (1) · Switzerland (1)
Asmaa Ellaithy, MD (1) · Jasper Gerritsen, MD PhD (1) · Seema Nagpal (1) · Xingyao Bu (1)